"Biological Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenously-synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.
| Descriptor ID |
D001685
|
| MeSH Number(s) |
D23
|
| Concept/Terms |
Biological Factors- Biological Factors
- Factor, Biological
- Factors, Biological
- Biologic Agents
- Agents, Biologic
- Biologic Factors
- Factors, Biologic
- Factor, Biologic
- Biologic Factor
- Biological Agents
- Agents, Biological
- Biological Factor
|
Below are MeSH descriptors whose meaning is more general than "Biological Factors".
Below are MeSH descriptors whose meaning is more specific than "Biological Factors".
This graph shows the total number of publications written about "Biological Factors" by people in this website by year, and whether "Biological Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Factors" by people in Profiles.
-
Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A?Case Series. J Investig Dermatol Symp Proc. 2020 11; 20(1):S50-S54.
-
Hepatitis B reactivation in patients on biologics: A perfect storm. J Am Acad Dermatol. 2022 01; 86(1):37-38.
-
Early markers of cardiovascular disease. Vascul Pharmacol. 2006 Nov; 45(5):277-80.
-
Marine pharmacology in 2001--2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol. 2005 Mar-Apr; 140(3-4):265-86.
-
Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar Biotechnol (NY). 2004 Jan-Feb; 6(1):37-52.
-
Diffuse lamellar keratitis: evaluation of etiology, histopathologic findings, and clinical implications in an experimental animal model. J Cataract Refract Surg. 2003 Mar; 29(3):542-9.
-
Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysis. Curr Pharm Des. 2003; 9(11):879-89.
-
Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol. 2002 Jul; 132(3):315-39.
-
Histamine releasing factors. Clin Exp Allergy. 1991 Jan; 21 Suppl 1:8-16.